Vijay Kumar

4.1k total citations
110 papers, 2.8k citations indexed

About

Vijay Kumar is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Vijay Kumar has authored 110 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pathology and Forensic Medicine, 21 papers in Molecular Biology and 20 papers in Organic Chemistry. Recurrent topics in Vijay Kumar's work include Autoimmune Bullous Skin Diseases (22 papers), Celiac Disease Research and Management (20 papers) and Cholinesterase and Neurodegenerative Diseases (18 papers). Vijay Kumar is often cited by papers focused on Autoimmune Bullous Skin Diseases (22 papers), Celiac Disease Research and Management (20 papers) and Cholinesterase and Neurodegenerative Diseases (18 papers). Vijay Kumar collaborates with scholars based in United States, India and Poland. Vijay Kumar's co-authors include Ernst H. Beutner, Tadeusz P. Chorzelski, Kari Alitalo, Stefania Jabłońska, Renhai Cao, Jacob Farnebo, Yihai Cao, Anna Eriksson, Lena Claesson‐Welsh and Philip A. Linden and has published in prestigious journals such as Proceedings of the National Academy of Sciences, American Journal of Clinical Nutrition and Oncogene.

In The Last Decade

Vijay Kumar

102 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vijay Kumar United States 24 891 710 648 551 532 110 2.8k
Woo Sung Moon South Korea 37 1.7k 1.9× 255 0.4× 628 1.0× 794 1.4× 786 1.5× 157 4.6k
Gerhard Seitz Germany 36 1.9k 2.2× 443 0.6× 770 1.2× 1.6k 2.9× 238 0.4× 119 5.0k
Sang Cheul Oh South Korea 35 1.9k 2.2× 478 0.7× 602 0.9× 918 1.7× 323 0.6× 192 4.9k
Vilmos Thomázy United States 26 2.6k 3.0× 144 0.2× 280 0.4× 591 1.1× 498 0.9× 46 4.7k
Joji Kitayama Japan 34 1.0k 1.1× 492 0.7× 215 0.3× 1.2k 2.1× 384 0.7× 174 3.9k
Sumio Sakamaki Japan 28 1.0k 1.1× 77 0.1× 436 0.7× 413 0.7× 305 0.6× 88 3.3k
Fumio Shimamoto Japan 40 1.3k 1.5× 440 0.6× 808 1.2× 1.4k 2.6× 496 0.9× 196 4.6k
Carsten Boltze Germany 29 750 0.8× 335 0.5× 373 0.6× 422 0.8× 117 0.2× 87 2.7k
Chris Tselepis United Kingdom 33 1.2k 1.4× 188 0.3× 181 0.3× 685 1.2× 180 0.3× 71 3.2k
Toshiyuki Nakayama Japan 35 1.6k 1.7× 163 0.2× 324 0.5× 1.0k 1.9× 199 0.4× 171 4.2k

Countries citing papers authored by Vijay Kumar

Since Specialization
Citations

This map shows the geographic impact of Vijay Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vijay Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vijay Kumar more than expected).

Fields of papers citing papers by Vijay Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vijay Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vijay Kumar. The network helps show where Vijay Kumar may publish in the future.

Co-authorship network of co-authors of Vijay Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Vijay Kumar. A scholar is included among the top collaborators of Vijay Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vijay Kumar. Vijay Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kumar, Vijay, Vishal Kumar, Naveen Kumar, et al.. (2025). In vitro and in vivo Investigations of 4-Substituted 2-Phenylquinazoline derivatives as multipotent ligands for the treatment of Alzheimer’s disease. Bioorganic Chemistry. 155. 108126–108126. 3 indexed citations
3.
4.
Kumar, Naveen, Vishal Kumar, Jayapriya Mishra, et al.. (2024). In Vitro and In Vivo Investigations of Chromone Derivatives as Potential Multitarget-Directed Ligands: Cognitive Amelioration Utilizing a Scopolamine-Induced Zebrafish Model. ACS Chemical Neuroscience. 15(14). 2565–2585. 10 indexed citations
5.
Sharma, Sunny, Vishal Singh Rana, Neerja Rana, et al.. (2023). Assessment of Microplastics Pollution on Soil Health and Eco-toxicological Risk in Horticulture. Soil Systems. 7(1). 7–7. 12 indexed citations
6.
Kumar, Vijay, et al.. (2023). Virtual screening and molecular dynamics simulation approach for the identification of potential multi-target directed ligands for the treatment of Alzheimer’s disease. Journal of Biomolecular Structure and Dynamics. 42(1). 509–527. 17 indexed citations
7.
8.
Dwivedi, Ashish Ranjan, et al.. (2022). Synthesis and Evaluation of Antimicrobial Activity of N-Substituted Indole Derivatives and Molecular Docking Studies. Current Organic Chemistry. 26(16). 1565–1574. 1 indexed citations
9.
Kumar, Bhupinder, Ashish Ranjan Dwivedi, Tania Arora, et al.. (2022). Design, Synthesis, and Pharmacological Evaluation of N-Propargylated Diphenylpyrimidines as Multitarget Directed Ligands for the Treatment of Alzheimer’s Disease. ACS Chemical Neuroscience. 13(14). 2122–2139. 33 indexed citations
10.
Prasad, Amit, Vinod Kumar, Ashish Ranjan Dwivedi, et al.. (2022). Benzotriazole Substituted 2-Phenylquinazolines as Anticancer Agents:Synthesis, Screening, Antiproliferative and Tubulin Polymerization InhibitionActivity. Current Cancer Drug Targets. 23(4). 278–292. 3 indexed citations
11.
Dwivedi, Ashish Ranjan, et al.. (2022). Design, synthesis and evaluation of 4-phenyl-1,2,3-triazole substituted pyrimidine derivatives as antiproliferative and tubulin polymerization inhibitors. Journal of Molecular Structure. 1267. 133592–133592. 13 indexed citations
12.
13.
Dwivedi, Ashish Ranjan, et al.. (2020). Role of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Different Disease States: Recent Updates. Current Medicinal Chemistry. 28(16). 3193–3215. 40 indexed citations
14.
Dwivedi, Ashish Ranjan, Vijay Kumar, Harmeet Kaur, et al.. (2020). Anti-proliferative potential of triphenyl substituted pyrimidines against MDA-MB-231, HCT-116 and HT-29 cancer cell lines. Bioorganic & Medicinal Chemistry Letters. 30(20). 127468–127468. 17 indexed citations
15.
Kumar, Vijay, et al.. (2019). Unusual Presentation of Multiple Myeloma: A Case Series. Annals of Medical and Health Sciences Research. 9(3). 1 indexed citations
16.
Dwivedi, Ashish Ranjan, Amandeep Thakur, Vijay Kumar, Ira Skvortsova, & Vinod Kumar. (2019). Targeting Cancer Stem Cells Pathways for the Effective Treatment of Cancer. Current Drug Targets. 21(3). 258–278. 19 indexed citations
17.
Singh, Satyendra Kumar, et al.. (2019). Comparison of efficacy of platelet-rich plasma therapy with or without topical 5% minoxidil in male-type baldness: A randomized, double-blind placebo control trial. Indian Journal of Dermatology Venereology and Leprology. 86(2). 150–150. 47 indexed citations
18.
Kumar, Vijay, et al.. (2015). A Study on Socio-demographic Profile and CD4 Count of HIV Infected Patients Attending ART Centre RIMS, Ranchi. 6(1). 12–17. 1 indexed citations
19.
Kumar, Vijay, et al.. (2001). The Prevalence and Clinical Characteristics of Celiac Disease in Juvenile Diabetes in Wisconsin. Journal of Pediatric Gastroenterology and Nutrition. 33(4). 462–465. 5 indexed citations
20.
Wilson, B. Dale, et al.. (1982). Linear immuno globulin a bullous dermatosis an immunologically defined disease. Journal of Investigative Dermatology. 78(4). 348. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Woo Sung Moon Breakdown of academic impact, for papers by Gerhard Seitz Breakdown of academic impact, for papers by Sang Cheul Oh Breakdown of academic impact, for papers by Vilmos Thomázy Breakdown of academic impact, for papers by Joji Kitayama Breakdown of academic impact, for papers by Sumio Sakamaki Breakdown of academic impact, for papers by Fumio Shimamoto Breakdown of academic impact, for papers by Carsten Boltze Breakdown of academic impact, for papers by Chris Tselepis Breakdown of academic impact, for papers by Toshiyuki Nakayama
Rankless by CCL
2026